LYNN BLODGETT Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LYNN BLODGETT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LYNN BLODGETT. LYNN BLODGETT is Executive Vice President in XEROX CORP ($XRX).
Latest Insider Trading Transactions of LYNN BLODGETT
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 01 2014 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 6.33 | 400,000 | 2,532,000 | 450,235 | |
May 01 2014 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 12.01 | 400,000 | 4,804,560 | 202,967 | 603 K to 203 K (-66.34 %) |
May 01 2014 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 6.33 | 400,000 | 2,532,000 | 602,967 | 203 K to 603 K (+197.08 %) |
Feb 10 2014 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.33 | 660,886 | 4,844,294 | 0 | |
Feb 10 2014 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 10.35 | 660,886 | 6,840,633 | 202,967 | 863.9 K to 203 K (-76.50 %) |
Feb 10 2014 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.33 | 660,886 | 4,844,294 | 863,853 | 203 K to 863.9 K (+325.61 %) |
Aug 13 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.33 | 47,642 | 349,216 | 660,886 | |
Aug 13 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 152,358 | 1,081,742 | 0 | |
Aug 13 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 10.13 | 47,642 | 482,594 | 202,967 | 250.6 K to 203 K (-19.01 %) |
Aug 13 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.33 | 47,642 | 349,216 | 250,609 | 203 K to 250.6 K (+23.47 %) |
Aug 13 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 10.13 | 69,776 | 706,803 | 202,967 | 272.7 K to 203 K (-25.58 %) |
Aug 13 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 10.07 | 82,582 | 831,237 | 272,743 | 355.3 K to 272.7 K (-23.24 %) |
Aug 13 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 152,358 | 1,081,742 | 355,325 | 203 K to 355.3 K (+75.07 %) |
Aug 12 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 200,000 | 1,420,000 | 152,358 | |
Aug 12 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 204,483 | 1,451,829 | 352,358 | |
Aug 12 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 6.33 | 117,560 | 744,155 | 850,235 | |
Aug 12 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 10.00 | 200,000 | 1,999,000 | 202,967 | 403 K to 203 K (-49.63 %) |
Aug 12 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 200,000 | 1,420,000 | 402,967 | 203 K to 403 K (+98.54 %) |
Aug 12 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 10.01 | 72,043 | 721,150 | 202,967 | 275 K to 203 K (-26.20 %) |
Aug 12 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.92 | 132,440 | 1,313,302 | 275,010 | 407.5 K to 275 K (-32.50 %) |
Aug 12 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 204,483 | 1,451,829 | 407,450 | 203 K to 407.5 K (+100.75 %) |
Aug 12 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.92 | 117,560 | 1,165,748 | 202,967 | 320.5 K to 203 K (-36.68 %) |
Aug 12 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 6.33 | 117,560 | 744,155 | 320,527 | 203 K to 320.5 K (+57.92 %) |
Aug 08 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 6.33 | 182,440 | 1,154,845 | 967,795 | |
Aug 08 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 6.33 | 595,517 | 3,769,623 | 1,150,235 | |
Aug 08 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.87 | 82,440 | 813,617 | 202,967 | 285.4 K to 203 K (-28.89 %) |
Aug 08 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.92 | 100,000 | 992,030 | 285,407 | 385.4 K to 285.4 K (-25.95 %) |
Aug 08 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 6.33 | 182,440 | 1,154,845 | 385,407 | 203 K to 385.4 K (+89.89 %) |
Aug 08 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.97 | 95,517 | 952,706 | 202,967 | 298.5 K to 203 K (-32.00 %) |
Aug 08 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.97 | 311,190 | 3,103,778 | 298,484 | 609.7 K to 298.5 K (-51.04 %) |
Aug 08 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 10.02 | 188,810 | 1,891,914 | 609,674 | 798.5 K to 609.7 K (-23.65 %) |
Aug 08 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 6.33 | 595,517 | 3,769,623 | 798,484 | 203 K to 798.5 K (+293.41 %) |
Jul 03 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 217,490 | 0 | 101,784 | |
Jul 03 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | A | 0.00 | 134,476 | 0 | 319,274 | |
Jul 03 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Payment of Exercise | F | 9.24 | 74,385 | 687,317 | 202,967 | 277.4 K to 203 K (-26.82 %) |
Jul 03 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Grant | A | 9.24 | 158,433 | 1,463,921 | 277,352 | 118.9 K to 277.4 K (+133.23 %) |
Jul 03 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Payment of Exercise | F | 9.24 | 102,113 | 943,524 | 118,919 | 221 K to 118.9 K (-46.20 %) |
Jul 03 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 0.00 | 217,490 | 0 | 221,032 | 3.5 K to 221 K (+6,140.32 %) |
May 13 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.00 | 42,685 | 384,118 | 3,542 | 46.2 K to 3.5 K (-92.34 %) |
May 13 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 8.96 | 66,386 | 594,865 | 46,227 | 112.6 K to 46.2 K (-58.95 %) |
Feb 07 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 171,330 | 0 | 184,798 | |
Feb 07 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Payment of Exercise | F | 8.02 | 62,259 | 499,317 | 112,613 | 174.9 K to 112.6 K (-35.60 %) |
Feb 07 2013 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 0.00 | 171,330 | 0 | 174,872 | 3.5 K to 174.9 K (+4,837.10 %) |
Jul 03 2012 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | A | 0.00 | 101,148 | 0 | 356,128 | |
Jul 06 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | A | 0.00 | 83,650 | 0 | 254,980 | |
Mar 03 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 194,332 | 1,379,757 | 556,841 | |
Mar 03 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 6.34 | 5,668 | 35,935 | 0 | |
Mar 03 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Payment of Exercise | F | 9.76 | 145,000 | 1,415,708 | 3,542 | 148.5 K to 3.5 K (-97.62 %) |
Mar 03 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.76 | 55,000 | 536,993 | 148,542 | 203.5 K to 148.5 K (-27.02 %) |
Mar 03 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 194,332 | 1,379,757 | 203,542 | 9.2 K to 203.5 K (+2,110.01 %) |
Mar 03 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 6.34 | 5,668 | 35,935 | 9,210 | 3.5 K to 9.2 K (+160.02 %) |
Feb 23 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | A | 0.00 | 171,330 | 0 | 171,330 | |
Jan 05 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 6.33 | 379,834 | 2,404,349 | 1,745,752 | |
Jan 05 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 11.75 | 34,722 | 408,008 | 3,542 | 38.3 K to 3.5 K (-90.74 %) |
Jan 05 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 11.75 | 45,112 | 530,111 | 38,264 | 83.4 K to 38.3 K (-54.11 %) |
Jan 05 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 11.59 | 300,000 | 3,478,020 | 83,376 | 383.4 K to 83.4 K (-78.25 %) |
Jan 05 2011 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 6.33 | 379,834 | 2,404,349 | 383,376 | 3.5 K to 383.4 K (+10,723.72 %) |
Mar 03 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 1,000,000 | 7,100,000 | 751,173 | |
Mar 03 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.53 | 1,000,000 | 9,525,800 | 3,542 | 1 M to 3.5 K (-99.65 %) |
Mar 03 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 1,000,000 | 7,100,000 | 1,003,542 | 3.5 K to 1 M (+28,232.64 %) |
Feb 26 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 436,122 | 3,096,466 | 1,751,173 | |
Feb 26 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 82,596 | 586,432 | 2,187,295 | |
Feb 26 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.25 | 436,122 | 4,035,350 | 3,542 | 439.7 K to 3.5 K (-99.19 %) |
Feb 26 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 436,122 | 3,096,466 | 439,664 | 3.5 K to 439.7 K (+12,312.87 %) |
Feb 26 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.25 | 82,596 | 764,021 | 3,542 | 86.1 K to 3.5 K (-95.89 %) |
Feb 26 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 82,596 | 586,432 | 86,138 | 3.5 K to 86.1 K (+2,331.90 %) |
Feb 19 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 1,122,800 | 7,971,880 | 167,057 | |
Feb 19 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 127,200 | 903,120 | 1,289,857 | |
Feb 19 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.07 | 1,122,800 | 10,184,021 | 3,542 | 1.1 M to 3.5 K (-99.69 %) |
Feb 19 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 1,122,800 | 7,971,880 | 1,126,342 | 3.5 K to 1.1 M (+31,699.60 %) |
Feb 19 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.01 | 127,200 | 1,145,818 | 3,542 | 130.7 K to 3.5 K (-97.29 %) |
Feb 19 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 127,200 | 903,120 | 130,742 | 3.5 K to 130.7 K (+3,591.19 %) |
Feb 23 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 564,224 | 4,005,990 | 2,269,891 | |
Feb 23 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 122,057 | 866,605 | 0 | |
Feb 23 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.10 | 45,000 | 319,500 | 122,057 | |
Feb 23 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.25 | 686,281 | 6,350,501 | 3,542 | 689.8 K to 3.5 K (-99.49 %) |
Feb 23 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 564,224 | 4,005,990 | 689,823 | 125.6 K to 689.8 K (+449.23 %) |
Feb 23 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 122,057 | 866,605 | 125,599 | 3.5 K to 125.6 K (+3,445.99 %) |
Feb 23 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 9.25 | 45,000 | 416,322 | 3,542 | 48.5 K to 3.5 K (-92.70 %) |
Feb 23 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.10 | 45,000 | 319,500 | 48,542 | 3.5 K to 48.5 K (+1,270.47 %) |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 7.00 | 991,940 | 6,943,580 | 0 | |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 6.23 | 258,528 | 1,610,629 | 0 | |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 5.31 | 43,422 | 230,571 | 0 | |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 6.23 | 450,000 | 2,803,500 | 258,528 | |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 5.31 | 83,915 | 445,589 | 43,422 | |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 8.77 | 1,250,468 | 10,967,730 | 3,542 | 1.3 M to 3.5 K (-99.72 %) |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 7.00 | 991,940 | 6,943,580 | 1,254,010 | 262.1 K to 1.3 M (+378.50 %) |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 6.23 | 258,528 | 1,610,629 | 262,070 | 3.5 K to 262.1 K (+7,298.93 %) |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 8.66 | 493,422 | 4,271,900 | 3,542 | 497 K to 3.5 K (-99.29 %) |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 5.31 | 43,422 | 230,571 | 496,964 | 453.5 K to 497 K (+9.57 %) |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 6.23 | 450,000 | 2,803,500 | 453,542 | 3.5 K to 453.5 K (+12,704.69 %) |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 8.51 | 31,560 | 268,607 | 3,542 | 35.1 K to 3.5 K (-89.91 %) |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Payment of Exercise | F | 8.51 | 52,355 | 445,593 | 35,102 | 87.5 K to 35.1 K (-59.86 %) |
Feb 12 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 5.31 | 83,915 | 445,589 | 87,457 | 3.5 K to 87.5 K (+2,369.14 %) |
Feb 10 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 5.31 | 79,855 | 424,030 | 127,337 | |
Feb 10 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Option Exercise | M | 5.31 | 111,646 | 592,840 | 207,192 | |
Feb 10 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 8.51 | 30,000 | 255,159 | 3,542 | 33.5 K to 3.5 K (-89.44 %) |
Feb 10 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Payment of Exercise | F | 8.51 | 49,855 | 424,032 | 33,542 | 83.4 K to 33.5 K (-59.78 %) |
Feb 10 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 5.31 | 79,855 | 424,030 | 83,397 | 3.5 K to 83.4 K (+2,254.52 %) |
Feb 10 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Sell | S | 8.50 | 41,900 | 356,150 | 3,542 | 45.4 K to 3.5 K (-92.21 %) |
Feb 10 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Payment of Exercise | F | 8.50 | 69,746 | 592,841 | 45,442 | 115.2 K to 45.4 K (-60.55 %) |
Feb 10 2010 | XRX | XEROX CORP | BLODGETT LYNN | Executive Vice Pres ... | Buy | M | 5.31 | 111,646 | 592,840 | 115,188 | 3.5 K to 115.2 K (+3,152.06 %) |
Page: 1